Respiratory Syncytial Virus (RSV) Diagnostics Market Report

Respiratory Syncytial Virus (RSV) Diagnostics Market Analysis Report By Product (DFA, RADT, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging) By End-Use, And Segment Forecasts, 2012 - 2022

  • Report ID: 978-1-68038-680-6
  • Number of Pages: 118
  • Format: Electronic (PDF)
  • Historical Range: 2012 - 2015
  • Industry: Healthcare

Table of Contents

Chapter 1 Methodology & Scope
                  1.1 Country-wise market calculation
                      1.1.1 Country-wise market: Base estimates
                      1.1.2 Global market: CAGR calculation
                  1.2 Region based segment share calculation
                  1.3 Primary Sources
                      1.3.1 Data for primary interviews in North America
                      1.3.2 Data for primary interviews in Europe
                      1.3.3 Data for primary interviews in Asia Pacific
                      1.3.4 Data for primary interviews in RoW
                  1.4 List of secondary sources
Chapter 2 Executive Summary
Chapter 3 Respiratory Syncytial Virus Diagnostics Industry Outlook
                  3.1 Respiratory Syncytial Virus Diagnostics Market Segmentation
                  3.2 Respiratory Syncytial Virus Diagnostics Market Size and Growth Prospects
                  3.3 Respiratory Syncytial Virus Diagnostics: Market Dynamics
                  3.4 Market Driver Analysis
                      3.4.1 Increasing incidence rate of respiratory infections
                      3.4.2 Rising neonatal population base
                      3.4.3 Increasing demand for in-vitro diagnostics
                      3.4.4 Increasing demand for point of care facilities
                  3.5 Market Restraint Analysis
                      3.5.1 High cost and limited standardization
                      3.5.2 Presence of various pathogens causing similar respiratory distress conditions
                  3.6 Key Opportunities Prioritized
                  3.7 Industry analysis Porter’s
                  3.8 Respiratory Syncytial Virus Diagnostics Company Market Share/ Competitive Landscape, 2014
                  3.9 Respiratory Syncytial Virus diagnostics market - PESTEL analysis
                  3.10 Respiratory Syncytial Virus Diagnostics Technology development analysis
Chapter 4 Respiratory Syncytial Virus Diagnostics Product Outlook
                  4.1 Respiratory Syncytial Virus diagnostics revenue share by product, 2014 & 2022
                  4.2 Direct Fluorescent Antibody (DFA) Method
                      4.2.1 DFA method market, 2012 - 2022 (USD Million)
                  4.3 Rapid Antigen Diagnostic Test (RADT)
                      4.3.1 RADT market, 2012 - 2022 (USD Million)
                  4.4 Molecular Diagnostics
                      4.4.1 Molecular diagnostics market, 2012 - 2022 (USD Million)
                  4.5 Chromatographic Immunoassay
                      4.5.1 Chromatographic immunoassay diagnostics market, 2012 - 2022 (USD Million)
                      4.5.2 Gravity-driven Test
                      4.5.3 Gravity-driven test market, 2012 - 2022 (USD Million)
                      4.5.4 Oligochromatography
                      4.5.5 Oligochromatography market, 2012 - 2022 (USD Million)
                  4.6 Diagnostic Imaging
                      4.6.1 Diagnostic imaging market, 2012 - 2022 (USD Million)
                  4.7 Gel Microdroplets
                      4.7.1 Gel microdroplets diagnostics market, 2012 - 2022 (USD Million)
                  4.8 Flow Cytometry
                      4.8.1 Flow cytometry diagnostics market, 2012 - 2022 (USD Million)
                  4.9 Others
                      4.9.1 Other diagnostics market, 2012 - 2022 (USD Million)
Chapter 5 Respiratory Syncytial Virus Diagnostics End-use Outlook
                  5.1 Respiratory Syncytial Virus diagnostics revenue share by end-use, 2014 & 2022
                  5.2 Hospitals
                      5.2.1 Respiratory Syncytial Virus diagnostics market, by hospitals 2012 - 2022 (USD Million)
                  5.3 Laboratory
                      5.3.1 Respiratory Syncytial Virus diagnostics market, by laboratory 2012 - 2022 (USD Million)
                  5.4 Clinics
                      5.4.1 Respiratory Syncytial Virus diagnostics market, by clinics 2012 - 2022 (USD Million)
                  5.5 Homecare
                      5.5.1 Respiratory Syncytial Virus diagnostics market, by homecare 2012 - 2022 (USD Million)
Chapter 6 Respiratory Syncytial Virus Diagnostics Regional Outlook
                  6.1 Respiratory Syncytial Virus diagnostics revenue share by region, 2014 & 2022
                  6.2 North America
                      6.2.1 North America Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.2.2 U.S.
                          6.2.2.1 U.S. Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.2.3 Canada
                          6.2.3.1 Canada Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                  6.3 Europe
                      6.3.1 Europe Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.3.2 UK
                          6.3.2.1 UK Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.3.3 Germany
                          6.3.3.1 Germany Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.3.4 France
                          6.3.4.1 France Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.3.5 Italy
                          6.3.5.1 Italy Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.3.6 Spain
                          6.3.6.1 Spain Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                  6.4 Asia Pacific
                      6.4.1 Asia Pacific Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.4.2 Japan
                          6.4.2.1 Japan Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
                      6.4.3 China
                          6.4.3.1 China Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
                      6.4.4 India
                          6.4.4.1 India Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                  6.5 Latin America
                      6.5.1 Latin America Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.5.2 Brazil
                          6.5.2.1 Brazil Respiratory Syncytial Virus diagnostics market 2012 - 2022 (USD Million)
                      6.5.3 Mexico
                          6.5.3.1 Mexico Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
                      6.5.4 Argentina
                          6.5.4.1 Argentina Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
                      6.5.5 Peru
                          6.5.5.1 Peru Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
                  6.6 MEA
                      6.6.1 MEA Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
                      6.6.2 South Africa
                          6.6.2.1 South Africa Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
                      6.6.3 Saudi Arabia
                          6.6.3.1 Saudi Arabia Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
Chapter 7 Competitive Landscape
                  7.1 Becton, Dickinson and Company
                      7.1.1 Company Overview
                      7.1.2 Financial Performance
                      7.1.3 Product Benchmarking
                      7.1.4 Strategic Initiatives
                  7.2 Novartis Diagnostics
                      7.2.1 Company Overview
                      7.2.2 Financial Performance
                      7.2.3 Product Benchmarking
                      7.2.4 Strategic Initiatives
                  7.3 Abbott Laboratories
                      7.3.1 Company Overview
                      7.3.2 Financial Performance
                      7.3.3 Product Benchmarking
                      7.3.4 Strategic Initiatives
                  7.4 Ortho Clinical Diagnostics
                      7.4.1 Company Overview
                      7.4.2 Financial Performance
                      7.4.3 Product Benchmarking
                      7.4.4 Strategic Initiatives
                  7.5 Thermo Fisher Scientific Inc.
                      7.5.1 Company Overview
                      7.5.2 Financial Performance
                      7.5.3 Product Benchmarking
                      7.5.4 Strategic Initiatives
                  7.6 Bio-Rad Laboratories Inc.
                      7.6.1 Company Overview
                      7.6.2 Financial Performance
                      7.6.3 Product Benchmarking
                  7.7 Hoffmann La Roche Limited
                      7.7.1 Company Overview
                      7.7.2 Financial Performance
                      7.7.3 Product Benchmarking
                      7.7.4 Strategic Initiatives
                  7.8 BioMerieux
                      7.8.1 Company Overview
                      7.8.2 Financial Performance
                      7.8.3 Product Benchmarking
                  7.9 DiaSorin SPA
                      7.9.1 Company Overview
                      7.9.2 Financial Performance
                      7.9.3 Product Benchmarking
                  7.10 EMD Millipore
                      7.10.1 Company Overview
                      7.10.2 Financial Performance
                      7.10.3 Product Benchmarking
                      7.10.4 Strategic Initiatives
                  7.11 Quidel Corporation
                      7.11.1 Company Overview
                      7.11.2 Financial Performance
                      7.11.3 Product Benchmarking
                      7.11.4 Strategic Initiatives
                  7.12 Alere Inc.
                      7.12.1 Company Overview
                      7.12.2 Financial Performance
                      7.12.3 Product Benchmarking
                      7.12.4 Strategic Initiatives
                  7.13 Coris BioConcept
                      7.13.1 Company Overview
                      7.13.2 Financial Performance
                      7.13.3 Product Benchmarking
                  7.14 Fast-track Diagnostics
                      7.14.1 Company Overview
                      7.14.2 Financial Performance
                      7.14.3 Product Benchmarking
                      7.14.4 Strategic Initiatives
                  7.15 Quest Diagnostics
                      7.15.1 Company Overview
                      7.15.2 Financial Performance
                      7.15.3 Product Benchmarking
                      7.15.4 Strategic Initiatives


List of Tables

TABLE 1 Country-wise market share percentage
TABLE 2 Factors used in segment share estimation
TABLE 3 Respiratory Syncytial Virus Diagnostics Market - Industry Summary & Key Buying Criteria, 2012 - 2022
TABLE 4 RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 5 RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 6 RSV diagnostics market, by region, 2012 - 2022 (USD Million)
TABLE 7 Respiratory Syncytial Virus Diagnostics Market - Key Market Driver Analysis
TABLE 8 Country-wise birth rate
TABLE 9 Respiratory Syncytial Virus Diagnostics Market - Key Market Restraint Analysis
TABLE 10 North America RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 11 North America chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 12 North America RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 13 U.S. RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 14 U.S. chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 15 U.S. RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 16 Canada RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 17 Canada chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 18 Canada RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 19 Europe RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 20 Europe chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 21 Europe RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 22 UK RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 23 UK chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 24 UK RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 25 Germany RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 26 Germany chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 27 Germany RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 28 France RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 29 France chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 30 France RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 31 Italy RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 32 Italy chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 33 Italy RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 34 Spain RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 35 Spain chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 36 Spain RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 37 Country wise infant population and birth rate of APAC countries for 2014
TABLE 38 Asia Pacific RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 39 Asia Pacific chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 40 Asia Pacific RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 41 Japan RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 42 Japan chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 43 Japan RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 44 China RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 45 China chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 46 China RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 47 India RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 48 India chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 49 India RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 50 Latin America RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 51 Latin America chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 52 Latin America RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 53 Age distribution for positive cases of Respiratory Syncytial Virus infection in Brazil
TABLE 54 Brazil RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 55 Brazil chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 56 Brazil RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 57 Mexico RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 58 Mexico chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 59 Mexico RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 60 Argentina RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 61 Argentina chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 62 Argentina RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 63 Peru RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 64 Peru chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 65 Peru RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 66 MEA RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 67 MEA chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 68 MEA RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 69 South Africa RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 70 South Africa chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 71 South Africa RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)
TABLE 72 Saudi Arabia RSV diagnostics market, by product, 2012 - 2022 (USD Million)
TABLE 73 Saudi Arabia chromatographic immunoassay market, by product, 2012 - 2022 (USD Million)
TABLE 74 Saudi Arabia RSV diagnostics market, by end-use, 2012 - 2022 (USD Million)


List of Figures

FIG. 1 Primary interviews in North America
FIG. 2 Primary interviews in Europe
FIG. 3 Primary interviews in Asia Pacific
FIG. 4 Primary interviews in RoW
FIG. 5 Respiratory Syncytial Virus diagnostics: Market segmentation
FIG. 6 Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 7 Respiratory Syncytial Virus diagnostics: Market dynamics
FIG. 8 Key opportunities prioritized
FIG. 9 Respiratory Syncytial Virus diagnostics market - Porter’s analysis
FIG. 10 Respiratory Syncytial Virus diagnostics company market share, 2014
FIG. 11 Respiratory Syncytial Virus diagnostics market - PESTEL analysis
FIG. 12 Advantages offered by techniques used for RSV diagnostics
FIG. 13 Disadvantages posed by techniques used for RSV Diagnostics
FIG. 14 Applications of techniques used for RSV Diagnostics
FIG. 15 Respiratory Syncytial Virus diagnostics market share, by product, 2014 & 2022
FIG. 16 DFA method market, 2012 - 2022 (USD Million)
FIG. 17 RADT market, 2012 - 2022 (USD Million)
FIG. 18 Molecular diagnostics market, 2012 - 2022 (USD Million)
FIG. 19 Chromatographic immunoassay diagnostics market, 2012 - 2022 (USD Million)
FIG. 20 Gravity-driven test market, 2012 - 2022 (USD Million)
FIG. 21 Oligochromatography market, 2012 - 2022 (USD Million)
FIG. 22 Diagnostic imaging market, 2012 - 2022 (USD Million)
FIG. 23 Gel microdroplets diagnostics market, 2012 - 2022 (USD Million)
FIG. 24 Flow cytometry diagnostics market, 2012 - 2022 (USD Million)
FIG. 25 Other diagnostics market, 2012 - 2022 (USD Million)
FIG. 26 Respiratory Syncytial Virus diagnostics market share, by end-use, 2014 & 2022
FIG. 27 Respiratory Syncytial Virus diagnostics market by hospital, 2012 - 2022 (USD Million)
FIG. 28 Respiratory Syncytial Virus diagnostics market, by laboratory 2012 - 2022 (USD Million)
FIG. 29 Respiratory Syncytial Virus diagnostics market, by clinics 2012 - 2022 (USD Million)
FIG. 30 Respiratory Syncytial Virus diagnostics market, by homecare 2012 - 2022 (USD Million)
FIG. 31 Respiratory Syncytial Virus diagnostics market share, by region, 2014 & 2022
FIG. 32 North America Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 33 U.S. Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 34 Canada Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 35 Europe Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 36 UK Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 37 Germany Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 38 France Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 39 Italy Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 40 Spain Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 41 Asia Pacific Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 42 Japan Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 43 China Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 44 India Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 45 Latin America Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 46 Brazil Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 47 Mexico Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 48 Argentina Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 49 Peru Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 50 MEA Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 51 South Africa Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)
FIG. 52 Saudi Arabia Respiratory Syncytial Virus diagnostics market, 2012 - 2022 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon